Slow Capital, Inc. Intellia Therapeutics, Inc. Transaction History

Slow Capital, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 16, 2019	SELL	$12.79 - $17.62 $270,713 - $372,944	-21,166 Closed	0 $0
Q4 2018 Jan 30, 2019	BUY	$11.39 - $27.13 $105,186 - $250,545	9,235 Added 77.4%	21,166 $289,000
Q3 2018 Nov 14, 2018	BUY	$25.78 - $32.6 $11,136 - $14,083	432 Added 3.76%	11,931 $341,000
Q2 2018 Aug 14, 2018	SELL	$20.02 - $30.79 $91,331 - $140,463	-4,562 Reduced 28.4%	11,499 $315,000
Q1 2018 May 11, 2018	BUY	$19.43 - $34.95 $15,466 - $27,820	796 Added 5.21%	16,061 $339,000
Q4 2017 Feb 15, 2018	BUY	$17.39 - $31.12 $265,458 - $475,046	15,265	15,265 $294,000

336

96.1M

1.06M

863K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $925M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Slow Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Slow Capital, Inc. with notifications on news.